Milestone Pharmaceuticals
MIST
MIST
44 hedge funds and large institutions have $22.9M invested in Milestone Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
+1
Holders Change %
+2.33%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
11
Increased
10
Reduced
9
Closed
10
Calls
$743K
Puts
$81K
Net Calls
+$662K
Net Calls Change
+$423K
Top Buyers
1 |
PBM
Propel Bio Management
Los Angeles,
California
|
+$660K |
2 |
UBS Group
Zurich,
Switzerland
|
+$410K |
3 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
+$272K |
4 |
Goldman Sachs
New York
|
+$232K |
5 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
+$215K |
Top Sellers
1 |
Morgan Stanley
New York
|
-$287K |
2 |
Millennium Management
New York
|
-$258K |
3 |
![]()
Group One Trading
Chicago,
Illinois
|
-$207K |
4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$200K |
5 |
LPL Financial
San Diego,
California
|
-$195K |